Xipiro discovered a novel molecule that squelches the generation of reactive oxygen species (ROS).
ROS is the hallmark of multiple diseases. Our discovery serves as a potent master control switch that can selectively turn off ROS.
By selectively modulating ROS production, Xipiro has demonstrated the ability to influence disease progression in multiple pre-clinical disease models including NASH, oncology, uremic cardiomyopathy, atherosclerosis, retinopathy, obesity, anemia/chronic kidney disease, and others.
Xipiro's discoveries are patent-protected and featured in over 100 publications including Nature and Science.
Xipiro is led by a team of leading scientists, clinicians, and experienced industry leaders.
Xiprio is headquartered in Huntington, WV.
Xipiro Inc.
Huntington, West Virginia
Copyright © 2020 Xipiro Inc - All Rights Reserved.